Literature DB >> 12075986

Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.

Thyagarajan Subramanian1, Deanna Marchionini, Elizabeth M Potter, Michael L Cornfeldt.   

Abstract

Attachment of donor cells to microcarriers has been reported to make them more tolerable for transplantation into the brain. Human retinal pigment epithelial (hRPE) cells have been previously reported to contain enzymes for the production of dopa. Therefore, we examined the host immune response and behavioral effects of xenotransplantation of hRPE cells attached to microcarriers (hRPE-M) into the striatum of unilateral dopamine-depleted rats. Thirty-four adult rats were lesioned with 6-OHDA injections into the medial forebrain bundle on the right side. After 5 weeks of testing for apomorphine-induced rotations (AIR), animals were randomized for right striatal surgery into the following four groups: hRPE-M (group 1), hRPE alone (group 2), microcarriers alone (group 3), or needle tract alone (group 4). Following surgery, animals were tested for AIR every 4 weeks for a period of 12-18 weeks and thereafter euthanized. There was a significant reduction in AIR scores posttransplantation in all groups of animals in the initial observation points at 4 weeks and 8 weeks. However, there was a gradual return to baseline scores in groups 2, 3, and 4 animals at 12 weeks and at 18 weeks only group 1 animals had statistically significant (p = 0.001, repeated measures ANOVA, means comparison, predetermined contrasts) reduction in AIR scores. Brain tissue from representative animals from each group was cut into 30-microm coronal sections, stained for cresyl violet, tyrosine hydroxylase (TH), and markers for host immune activation. Sections through the striatum from group 1 animals revealed microcarriers with attached cells resembling RPE cells. No evidence of transplanted hRPE cells could be detected in sections from group 2 animals while those from groups 3 and 4 animals showed microcarriers and a needle tract alone, respectively. There was no host TH-immunoreactive sprouting response in the striatum in any of the groups and the host immune response was minimal. These results suggest that intrastriatal hRPE-M xenotransplantation into rats is well tolerated without systemic immunosuppression and that such transplants may provide behavioral benefit for parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075986

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  19 in total

1.  Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.

Authors:  Shichun Peng; Yilong Ma; Joseph Flores; Michael Cornfeldt; Branka Mitrovic; David Eidelberg; Doris J Doudet
Journal:  J Nucl Med       Date:  2016-04-07       Impact factor: 10.057

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

3.  Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.

Authors:  M Angela Cenci; Håkan Widner
Journal:  Nat Rev Neurol       Date:  2011-07-19       Impact factor: 42.937

4.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

5.  Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Authors:  Lihong Bu; Renfei Li; Hongguang Liu; Wei Feng; Xiaoxing Xiong; Heng Zhao; Douglas Vollrath; Baozhong Shen; Zhen Cheng
Journal:  Radiology       Date:  2014-04-20       Impact factor: 11.105

6.  Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.

Authors:  Kaspar Russ; Joseph Flores; Tomasz Brudek; Doris J Doudet
Journal:  J Neural Transm (Vienna)       Date:  2017-02-04       Impact factor: 3.575

7.  A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

Authors:  Christopher A Lieu; Allen R Kunselman; Bala V Manyam; Kala Venkiteswaran; Thyagarajan Subramanian
Journal:  Parkinsonism Relat Disord       Date:  2010-05-31       Impact factor: 4.891

8.  Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson's disease.

Authors:  Hou-Liang Zhang; Jian-Jun Wu; Hui-Min Ren; Jian Wang; Ya-Ru Su; Yu-Ping Jiang
Journal:  Neurosci Bull       Date:  2007-05       Impact factor: 5.203

9.  Transplantation of human retinal pigment epithelial cells in the nucleus accumbens of cocaine self-administering rats provides protection from seeking.

Authors:  Kala Venkiteswaran; Danielle N Alexander; Matthew D Puhl; Anand Rao; Amanda L Piquet; Jennifer E Nyland; Megha P Subramanian; Puja Iyer; Matthew M Boisvert; Erin Handly; Thyagarajan Subramanian; Patricia Sue Grigson
Journal:  Brain Res Bull       Date:  2015-11-10       Impact factor: 4.077

10.  Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.

Authors:  Ming Ming; Xuping Li; Xiaolan Fan; Dehua Yang; Liang Li; Sheng Chen; Qing Gu; Weidong Le
Journal:  J Transl Med       Date:  2009-06-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.